{"id":"https://openalex.org/W2102846708","doi":null,"title":"Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.","display_name":"Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2102846708","mag":"2102846708","pmid":"https://pubmed.ncbi.nlm.nih.gov/11801546"},"language":"en","primary_location":{"id":"pmid:11801546","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032920417","display_name":"John Robert Mackey","orcid":"https://orcid.org/0000-0002-3489-2161","observed_orcids":["https://orcid.org/0000-0002-3489-2161"]},"institutions":[{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"John R Mackey","raw_affiliation_strings":["Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2 Canada. johnmack@cancerboard.ab.ca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2 Canada. johnmack@cancerboard.ab.ca","institution_ids":["https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006322283","display_name":"Lori L. Jennings","orcid":"https://orcid.org/0000-0001-5130-8417","observed_orcids":["https://orcid.org/0000-0001-5130-8417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lori L Jennings","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017848401","display_name":"Marilyn L. Clarke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marilyn L Clarke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108503205","display_name":"Cheryl L Santos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl L Santos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112174447","display_name":"Laith Dabbagh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laith Dabbagh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036622069","display_name":"Michaela V\u0161iansk\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michaela Vsianska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052243751","display_name":"Sheryl L. Koski","orcid":"https://orcid.org/0000-0003-0255-7200","observed_orcids":["https://orcid.org/0000-0003-0255-7200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sheryl L Koski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015441177","display_name":"Robert W. Coupland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert W Coupland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034487444","display_name":"Stephen A. Baldwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen A Baldwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059843872","display_name":"J YOUNG","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D Young","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113882809","display_name":"Carol E. Cass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol E Cass","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3902,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.89168846,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":"1","first_page":"110","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.4713999927043915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.4713999927043915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.22609999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.1289999932050705,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hent1","display_name":"hENT1","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ent1","display_name":"equilibrative nucleoside transporter 1","score":0.9599999785423279},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.925000011920929},{"id":"https://openalex.org/keywords/immunohistochemical-staining","display_name":"immunohistochemical staining","score":0.7929999828338623},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9039999842643738},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/5-deoxy-5-fluorouridine","display_name":"5'-deoxy-5-fluorouridine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mda-mb-435s-cells","display_name":"MDA-MB-435S cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6370000243186951},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.8324365615844727},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.5707986354827881},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5483407378196716},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5347762107849121},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.511017918586731},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.498218297958374},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4882698059082031},{"id":"https://openalex.org/C3018521938","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast carcinoma","level":4,"score":0.4492166042327881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4343019723892212},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3959543704986572},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3799794614315033},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35160866379737854},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10023263096809387},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000345","descriptor_name":"Affinity Labels","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013868","descriptor_name":"Thioinosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013868","descriptor_name":"Thioinosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D033721","descriptor_name":"Equilibrative Nucleoside Transporter 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:11801546","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comparative Study"},{"id":"pmid:12912975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12912975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comment"},{"id":"mag:2102846708","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11801546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W251703332","https://openalex.org/W1499209710","https://openalex.org/W1499766894","https://openalex.org/W1547953498","https://openalex.org/W1594700207","https://openalex.org/W1596537940","https://openalex.org/W1831079403","https://openalex.org/W1869404997","https://openalex.org/W1939003096","https://openalex.org/W1963517397","https://openalex.org/W1967675162","https://openalex.org/W1981040381","https://openalex.org/W1993790910","https://openalex.org/W2000646600","https://openalex.org/W2001100951","https://openalex.org/W2010871781","https://openalex.org/W2016971348","https://openalex.org/W2023813795","https://openalex.org/W2030395635","https://openalex.org/W2042118988","https://openalex.org/W2044837239","https://openalex.org/W2045651800","https://openalex.org/W2048312581","https://openalex.org/W2050818040","https://openalex.org/W2061147784","https://openalex.org/W2074333534","https://openalex.org/W2077648160","https://openalex.org/W2084248431","https://openalex.org/W2093790579","https://openalex.org/W2097467460","https://openalex.org/W2101017561","https://openalex.org/W2117569814","https://openalex.org/W2143854154","https://openalex.org/W2145799655","https://openalex.org/W2178573742","https://openalex.org/W2340279466","https://openalex.org/W2343100729","https://openalex.org/W2401812172","https://openalex.org/W2416974006","https://openalex.org/W2419410581","https://openalex.org/W2428348439","https://openalex.org/W2439624594","https://openalex.org/W2473943077"],"related_works":["https://openalex.org/W1581668977","https://openalex.org/W2019084905","https://openalex.org/W3031725733","https://openalex.org/W2131555383","https://openalex.org/W2055142365","https://openalex.org/W2100780413","https://openalex.org/W1968323734","https://openalex.org/W2155703416","https://openalex.org/W2131025996","https://openalex.org/W2241255079"],"abstract_inverted_index":{"Gemcitabine":[0],"and":[1,26,50,62,86,167,247],"capecitabine":[2,51,60,78,116,248],"are":[3],"nucleoside":[4,31,226],"analogues":[5],"used":[6],"in":[7,21,33,42,83,139,249],"chemotherapy":[8],"strategies":[9],"for":[10,240],"the":[11,23,45,57,77,84,102,125,133,161,210,242,250],"treatment":[12,251],"of":[13,76,88,95,99,105,114,127,136,144,165,209,231,245,252],"breast":[14,119,147,182,253],"cancer.":[15,254],"We":[16,122,215],"previously":[17,222],"demonstrated":[18],"that":[19,108,205,217],"deficiency":[20,220],"hENT1,":[22,166],"most":[24],"abundant":[25],"widely":[27],"distributed":[28],"plasma":[29],"membrane":[30],"transporter":[32],"human":[34,67],"cells,":[35],"confers":[36],"high-level":[37],"resistance":[38],"to":[39,73,131],"gemcitabine":[40,246],"toxicity":[41,52],"vitro,":[43],"whereas":[44],"relationship":[46,58],"between":[47,59],"hENT1":[48,63,109,134,176,213,219,232],"activity":[49],"is":[53],"unknown.":[54],"To":[55],"determine":[56],"cytotoxicity":[61],"abundance,":[64],"cultured":[65],"MDA-MB-435s":[66],"mammary":[68],"carcinoma":[69],"cells":[70,138],"were":[71,149,212],"exposed":[72],"graded":[74],"concentrations":[75],"metabolites,":[79],"5'-deoxy-5-fluorouridine":[80],"or":[81],"5-fluorouracil,":[82],"presence":[85,98],"absence":[87],"nitrobenzylmercaptopurine":[89],"ribonucleoside":[90],"(NBMPR),":[91],"a":[92,156,173,237],"tight-binding":[93],"inhibitor":[94],"hENT1.":[96],"The":[97],"NBMPR":[100],"reduced":[101],"cytotoxic":[103],"effects":[104],"5'-deoxy-5-fluorouridine,":[106],"indicating":[107],"also":[110],"enabled":[111],"cellular":[112],"uptake":[113],"this":[115],"metabolite":[117],"by":[118],"cancer":[120],"cells.":[121],"report":[123],"here":[124],"development":[126],"an":[128],"immunohistochemical":[129,229],"method":[130],"assess":[132],"abundance":[135],"malignant":[137],"solid":[140],"tumors.":[141],"Frozen":[142],"sections":[143],"33":[145],"primary":[146],"cancers":[148],"stained":[150],"with":[151,185,189,193,197,201,225],"monoclonal":[152],"antibodies":[153],"raised":[154],"against":[155],"synthetic":[157],"peptide":[158],"derived":[159],"from":[160],"large":[162],"intracellular":[163],"loop":[164],"staining":[168,177,230],"intensity":[169,178],"was":[170],"scored":[171],"on":[172],"0-4+":[174],"scale.":[175],"varied":[179],"markedly":[180],"among":[181],"samples":[183],"(4":[184],"score":[186,190,194,198,202],"0,":[187],"5":[188],"1+,":[191],"7":[192],"2+,":[195],"14":[196],"3+,":[199],"3":[200],"4+),":[203],"suggesting":[204],"at":[206],"least":[207],"9":[208],"tumors":[211],"deficient.":[214],"conclude":[216],"because":[218],"has":[221],"been":[223],"associated":[224],"drug":[227],"resistance,":[228],"warrants":[233],"further":[234],"study":[235],"as":[236],"predictive":[238],"tool":[239],"guiding":[241],"appropriate":[243],"use":[244]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}